KN026 (anti-HER2 bispecific antibody) in patients with previously treated, advanced HER2-expressing gastric or gastroesophageal junction cancer.
Xu J, Ying J, Liu R, Wu J, Ye F, Xu N, Zhang Y, Zhao R, Xiang X, Wang J, Lin X, Xu H, Gao S, Luo S, Guo B, Li X, Su Y, Wang Q.
Xu J, et al. Among authors: ye f.
Eur J Cancer. 2023 Jan;178:1-12. doi: 10.1016/j.ejca.2022.10.004. Epub 2022 Oct 19.
Eur J Cancer. 2023.
PMID: 36370604
Free article.
Clinical Trial.